SLC5A2 and heart failure: With regard to the beneficial effects of SGLT2 inhibitors on heart failure, it was initially considered that SGLT2 inhibitors have no direct effect on cardiomyocytes because SGLT2 is not expressed in the heart in either healthy subjects or under pathological conditions (5).